Since we entered the era of industrialization, air pollution is increasingly threatening our health. In addition, foods with artificial additives are another problem. The aim is to help our body cope with changes in our environment and to protect it optimally against external influences.
Probio-A contains three strains of lactic acid bacteria. Scientific studies have shown that Probio-A reduces inflammatory reactions in atopic dermatitis and alleviates respiratory allergies. Probio-A acts on the immune system, reducing the production of IgE and maintaining a balanced Th1 and Th2 profile, preventing allergies.
The strains in Probio-A are obtained by a fermentation process, freeze-dried and subjected to a patented five-layer microencapsulation technology to protect and preserve each individual probiotic strain optimally. It is a white to cream-coloured, free-flowing powder with high stability.
From the moment Probio-A is processed in a finished product, the probiotic can be stored at room temperature.
Pediococcus acidilactici PA320
Lactobacillus plantarum LP109
Lactobacillus plantarum LP110
1.0 x 1011 CFU/g
Deep-layer liquid state incubation
Identification of microbe
16S rDNA gene sequencing
Recommended scientific dosage
2.5 x 1010 CFU
The probiotic strains used in the formula Probio-A belong to the list of micro-organisms that have obtained Qualified Presumption of Safety (QPS) status, defined by EFSA in Europe (2007) because of their safe use in food (1).
(1) Annex II of Regulation (EU) No 1169/2011
Fermedics offers you on request all technical data of this ingredient, such as Certificate of Analysis (COA).
MOQ (minimum order quantity) 15 kg